Avibactam Sodium is a non-beta-lactam beta-lactamase inhibitor that restores antibacterial activity against ESBL- and KPC-producing Gram-negative pathogens when combined with cephalosporins such as ceftazidime. Simson Pharma's Avibactam Sodium reference standard and impurities support QC for these increasingly important combination antibiotics.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Avibactam Sodium Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.